Siemens Begins Delivering CE-IVD Registered Coronavirus SARS-CoV-2 Test Kit
Siemens Healthineers (Erlangen, Germany) has registered its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay2 test kit for diagnostic use with the Luxembourg Ministry of Health, allowing for its immediate rollout for diagnostic use in Europe. More...30 Apr 2020
Molecular Diagnostics (MDx) And Lateral Flow Assays (LAFs) Dominate COVID-19 Diagnostics, Says New Report
The need for universal and massive testing across the population has led to a race for technology innovations for COVID-19 diagnostics. From the technological perspective, molecular diagnostics (MDx) and lateral flow assays (LAFs) dominate COVID-19 diagnostics. More...30 Apr 2020
Development of Antibody Research Could Help Prevent Sepsis Induced by COVID-19
Scientists at the Feinstein Institutes for Medical Research (Manhasset, NY, USA) have discovered the development of novel antibody strategy to effectively prevent the association between a harmless protein and a disease mediator that could lead to sepsis death. More...30 Apr 2020
Active Compound in Popular Heartburn Drug Pepcid Being Tested for COVID-19 Treatment
A trial for famotidine, the active compound in the over-the-counter heartburn medication Pepcid, is underway at the Feinstein Institutes for Medical Research (Manhasset, NY, USA) to study if the drug can make a difference in the treatment of COVID-19 patients. More...29 Apr 2020
Coronavirus Targets Cells in Lungs, Nose and Intestines, Find MIT Researchers
Researchers at the Massachusetts Institute of Technology {(MIT) Cambridge, MA, USA} have identified specific types of cells that appear to be targets of the coronavirus that is causing the COVID-19 pandemic. More...29 Apr 2020
Menarini Explores Use of Proprietary CELLSEARCH Technology to Study Progression of COVID-19 Disease
Menarini Silicon Biosystems (Bologna, Italy) is exploring the possible use of its proprietary CELLSEARCH technology to study the progression of COVID-19 disease --and to potentially identify patients who may be at risk of developing the most severe complications of the disease. More...29 Apr 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Mini C-arm Imaging System
Fluoroscan InSight FD
New
Standing Sling
Sara Flex
In Other News
Eli Lilly and AbCellera Use AI to Slash Antibody Selection Time for COVID-19
BIOTECON Launches microproof® SARS-CoV-2 Screening/Identification Kits
DiaSorin’s LIAISON SARS-CoV-2 S1/S2 IgG Test Receives FDA Emergency Use Authorization
ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits
Pacing System Helps Wean COVID-19 Patients Off Ventilators
AI-based Infectious Disease Surveillance System Sent First Warning of Novel Coronavirus
Leinco Technologies and Vanderbilt University Medical Center to Jointly Develop Rapid, POC, Immunodiagnostic COVID-19 Test
Severely Ill Patients with SARS-CoV-2 Virus Respond to Blood-Clot-Busting Drug
DNA-based Vaccine Could Deliver Potent and Long-Lasting Responses to COVID-19
International Consortium Investigates Overactive Immune Cells as Cause of COVID-19 Deaths
Oxford Researchers Begin Testing COVID-19 Vaccine in Human Volunteers
Sanofi and Regeneron to Scale Back Late-Stage Trial of Kevzara after Negligible Results
Merck Partners with Institute for Systems Biology for COVID-19 Drug, Vaccine Target Discovery
Ortho’s Second COVID-19 Antibody Test with 100% Specificity Launched
Radiologists Warned to Watch Out for Possible Blood Clot Dangers in COVID-19 Patients
Coronavirus Could Have Mutated into More Than 30 Deadlier Strains, Finds Study
Coronavirus Attacks Blood Vessels Across Body to Cause Multiple Organ Failure, Finds Study
First-in-Human Trials of Multiple Highly Potent, Neutralizing Antibodies Against COVID-19 on Track
Vela Diagnostics Receives CE-IVD Mark for COVID-19 Detection Test
CRISPR-Based Test Detects SARS-CoV-2 from Respiratory Swab RNA Extracts in 45 Minutes
Stem Cell Therapy Shows 83% Survival in COVID-19 Patients Dependent on Ventilator
AI Platform Creates ‘Cocktail’ of Therapeutic Peptides for Treatment of COVID-19
'Elite' Antibodies from COVID-19 Survivors Used to Develop Potent Therapies
